The change of name is in line with the new brand strategy that the Sartorius Executive Board decided to implement. This strategy is focused on considerably streamlining the brand image within the Group, reducing complexity and strengthening the core brand Sartorius. The new name associates the internationally well-established acronym BBI with Sartorius, and thus reflects the successful integration of the company into the Sartorius Group.
The areas of core competence of Sartorius BBI Systems GmbH are in the development and production of fermenters and bioreactors for laboratory use, all the way to qualified and automated commercial-scale production systems.
By acquiring BBI in 2000, Sartorius substantially extended its performance portfolio as a supplier to the pharmaceutical / biotech industry by adding the equipment components for fermentation and cell culture technology.
This press release contains statements about the future development of the Sartorius Group. We cannot guarantee that the content of these statements will actually apply because these statements are based upon assumptions and estimates that harbor certain risks and uncertainties.
This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.
A profile of Sartorius BBI Systems GmbH
The company headquartered in Melsungen, a city in the northern part of the German state of Hesse, was founded in 1987 and acquired in 2000 by Sartorius AG based in Goettingen, Germany. The core areas of expertise of Sartorius BBI Systems are in the development and production of fermenters and bioreactors for applications in the laboratory, in production and in the corresponding automation and controlling units. Sartorius BBI Systems essentially supplies the pharmaceutical / biotech industry worldwide. With a workforce of a good 400 persons, the company is represented with its production sites in Germany, Italy, the U.S., and India, and with sales companies in more than 50 countries.
A profile of Sartorius AG
Sartorius AG is an internationally leading process technology supplier covering the segments of biotechnology and mechatronics. In 2003, the technology group earned sales revenue of 442.3 million euros (preliminary result). The Goettingen-based company founded in 1870 currently employs a good 3,660 persons. Its biotechnology segment focuses on filtration and separation applications, fermenters and proteomics. The mechatronics segment particularly consists of products for measurement and automation technology in laboratory and industrial applications.
Sartorius key customers are from the pharmaceutical, chemical and food and beverage industries and from numerous research and educational institutes of the public sector.
Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.